Follow
Debjani Patra
Debjani Patra
Senior Scientist I at Novartis Institute for Biomedical Research
Verified email at novartis.com
Title
Cited by
Cited by
Year
Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors
M Saldivia, E Fang, X Ma, E Myburgh, JBT Carnielli, C Bower-Lepts, ...
Nature microbiology 5 (10), 1207-1216, 2020
502020
Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections
SPS Rao, MK Gould, J Noeske, M Saldivia, RS Jumani, PS Ng, O René, ...
Science 380 (6652), 1349-1356, 2023
142023
Discovery of novel quinoline-based proteasome inhibitors for Human African Trypanosomiasis (HAT)
DC Koester, VM Marx, S Williams, J Jiricek, M Dauphinais, O René, ...
Journal of medicinal chemistry 65 (17), 11776-11787, 2022
72022
Medium-throughput Assay Development to Identify Trypanosoma Cruzi CDC Like Kinase (CLK1) Enzyme Inhibitors
D Patra
California State University, East Bay, 2021
2021
Creation of a functional unc-11/PICALM GFP knock-in by CRISPR
M Gallegos, A Hermes, D Patra
Micropublication Biology 2021, 2021
2021
Hollow fibre infection model for investigating the long-term culture of trypanosome parasites and their response to therapy
R Sterritt, S Lakshminarayana, M Saldivia, D Patra, S Rao, C Osborne
BRITISH JOURNAL OF PHARMACOLOGY 177 (11), 2613-2614, 2020
2020
DRUG DISCOVERY EFFORTS AND DEVELOPMENT OF KINETO-PLASTID ASSAYS AT NOVARTIS INSTITUTES FOR TROPICAL DISEASES
L Pei, SM Concepcion, H Cheung, YL Chen, S Rao, S Williams, J Gable, ...
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE 113, S90-S90, 2019
2019
The design and synthesis of drug-like trypanosome alternative oxidase inhibitors for the treatment of African trypanosomiasis
R West
University of Sussex, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–8